Skip to main content
Log in

Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Bougle A et al (2022) Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial. Intensive Care Med. https://doi.org/10.1007/s00134-022-06690-5

    Article  PubMed  Google Scholar 

  2. Chastre J et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(19):2588–2598

    Article  CAS  Google Scholar 

  3. Schumi J, Wittes JT (2011) Through the looking glass: understanding non-inferiority. Trials 12:106

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph Sassine.

Ethics declarations

Conflicts of interest

The authors declare no competing interests related to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siegrist, E.A., Sassine, J. Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Intensive Care Med 48, 963–964 (2022). https://doi.org/10.1007/s00134-022-06754-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-022-06754-6

Navigation